OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
Toni K. Choueiri, Jaime R. Merchan, Robert A. Figlin, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 1, pp. 64-73
Closed Access | Times Cited: 3

Showing 3 citing articles:

Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor–Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas
Rana R. McKay, Renu Eapen, Elizabeth Wulff‐Burchfield, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access

Belzutifan in von Hippel-Lindau disease
Chiara Ciccarese, Roberto Iacovelli, Giampaolo Tortora
The Lancet Oncology (2025)
Closed Access

Molecular Mechanisms of Drug Resistance in Clear Cell Renal Cell Carcinoma
Nicoletta Bianchi, Pietro Ancona, Gianluca Aguiari
Cancers (2025) Vol. 17, Iss. 10, pp. 1613-1613
Open Access

Fatal intracranial haemorrhage shortly after belzutifan initiation in von Hippel–Lindau (VHL) disease-associated haemangioblastoma
Scott T.C. Shepherd, Christian Kelly‐Morland, S Drage, et al.
ESMO Open (2025) Vol. 10, Iss. 5, pp. 105109-105109
Open Access

Page 1

Scroll to top